CIK 0001802665 · Large accelerated filer
Harmony Biosciences Holdings, Inc.
Sign in to watch- Ticker
- HRMY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822279923
- Phone
- (484) 539-9800
- Business address
- 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,108,586
- in 2 filings
Net −$3,108,586. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-05 | Valor IV Pharma Holdings, LLC 10% owner | Sale | −600,000 | $30.30 | $18.2M | 6,618,033 |
| 2024-11-05 | Marshman Fund Trust II 10% owner | Sale | −600,000 | $30.30 | $18.2M | 6,051,120 |
| 2024-11-01 | Valor IV Pharma Holdings, LLC 10% owner | Sale | −4,000,000 | $30.30 | $121.2M | 7,218,033 |
| 2024-11-01 | Marshman Fund Trust II 10% owner | Sale | −4,000,000 | $30.30 | $121.2M | 6,651,120 |
| 2024-10-29 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +21,496 | $24.00 | $516K | 21,496 |
| 2024-10-29 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −21,496 | $40.47 | $870K | 0 |
| 2024-10-29 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise · Stock Option 10b5-1 | −21,496 | 28,972 | ||
| 2024-10-03 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | −35,652 | $35.05 | $1.2M | 705 |
| 2024-10-03 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | −705 | $35.62 | $25K | 0 |
| 2024-10-01 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise | +400 | $24.00 | $10K | 400 |
| 2024-10-01 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | −400 | $40.19 | $16K | 0 |
| 2024-10-01 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise · Stock Option | −400 | 50,468 | ||
| 2024-09-30 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise | +60,000 | 60,000 | ||
| 2024-09-30 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −23,643 | $40.00 | $946K | 36,357 |
| 2024-09-30 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units | −60,000 | 90,000 | ||
| 2024-09-30 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Option exercise | +60,000 | 60,000 | ||
| 2024-09-30 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −32,052 | $40.00 | $1.3M | 27,948 |
| 2024-09-30 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −60,000 | 90,000 | ||
| 2024-09-30 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise | +35,846 | $24.00 | $860K | 35,846 |
| 2024-09-30 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale | −35,846 | $40.03 | $1.4M | 0 |
Page 9 of 14 · 268 trades